tirzepatide price in pak Getz Pharma launches Tirzee Inj, a new diabetes and obesity treatment. | Afzaal Ahmad posted on the topic Breaking News!* The global breakthrough
Description
Access in the Philippines requires a prescription and proper clinical guidance
Compound Tirzepatide is a dual GIP and GLP-1 receptor agonist used to treat type 2 diabetes and support long-term weight management
With promising outcomes in both diabetic and non-diabetic populations, ongoing research is exploring Tirzepatides broader use in obesity and cardiovascular risk reduction
The clinical analog already exists
[2] [3] Comparing Clinical Trials A randomized trial compared tirzepatide (10 mg or 15 mg) to semaglutide (1.7 mg or 2.4 mg) in adults with obesity but without type 2 diabetes over 72 weeks, showing tirzepatides superior weight loss and waist circumference reduction
The design and baseline characteristics have been published, confirming a highrisk cohort with longstanding diabetes and established ASCVD
